1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Antibiotic Discovery Hurdles: Could Data Sharing, Research Hub Solve Problem?

 
• By Brenda Sandburg

With input from industry, Pew Charitable Trusts proposes formation of entity dedicated to basic research; first step is finding someone to fund the estimated $200m cost for five-year initiative.

The Pew Charitable Trusts is calling for the formation of a scientific group dedicated to overcoming barriers in basic research that impede the discovery of new antibiotics.

While stakeholders have previously focused on regulatory and economic hurdles to antibiotic development, Pew has targeted the root of the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D

Swissmedic Launches Pilot To Expedite Clinical Trial Applications

 
• By Anabel Costa-Ferreira

Swiss health care products agency Swissmedic will launch a pilot in July to fast track clinical trial applications, which the agency claims will place Switzerland at the forefront compared to other European countries.

No ‘Doomsday’ For US Pharma Despite Political Uncertainties, EU Industry Chief Says

 
• By Eliza Slawther

While challenges in the US present an “incredible opportunity” for Europe, there is no “doomsday” happening there, Stefan Oelrich, the newly-announced president of European pharma industry federation EFPIA says.

EU Countries Rally Behind Novel Pathway For Combined Drug/IVD Trials

 
• By Vibha Sharma

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.